Alopecia areata - Ialopecia Areata
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Ialopecia Areata (Alopecia areata) ibonwa ngasemva entlokweni. Kwiimeko eziqhelekileyo, kubonakala ngokukhawuleza kunye nomphezulu ogudileyo ngokupheleleyo kunye nobukhulu be-2-3 cm.
References
Alopecia areata yimeko apho amajoni akho omzimba ahlasela iifollicles zeenwele zakho, ekhokelela ekulahlekeni kweenwele okwethutyana ngaphandle kokulimala. Ingabonakalisa njengamabala okulahleka kweenwele okanye ichaphazele i-scalp yakho yonke okanye umzimba, ichaphazela malunga ne-2% yabantu kwinqanaba elithile ebomini babo. Icala eliphambili libonakala liyintlupheko ekukhuselweni kwendalo malunga neenwele zeenwele.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata yimeko apho amajoni omzimba ahlasela iifollicles zeenwele, ezibangela ukulahleka kweenwele entloko kunye namanye amalungu anoboya emzimbeni. Ichaphazela malunga ne-2% yabantu kwihlabathi liphela. Ngelixa inokwenzeka nakweyiphi na iminyaka, ixhaphake kakhulu ebantwaneni kunabantu abadala (1. 92% vs. 1. 47%) . Abasetyhini, ngakumbi abo bangaphezulu kweminyaka engama-50, badla ngokufumana ngaphezulu kwamadoda. Ukutofa i-corticosteroids ngokuthe ngqo kwiindawo ezichaphazelekayo kubonise iziphumo ezingcono kunokuzisebenzisa ngokwezihloko.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
I-Alopecia areata kukholelwa ukuba sisifo esizimelayo esinxulumene ne-immune system ye-follicles yeenwele. Indlela esisiseko ibandakanya ukusilela ngumzimba ukuqaphela iiseli zawo, kunye nokutshatyalaliswa kwe-immune-mediated ye-follicle yeenwele.
○ Unyango ― OTC Amachiza
Abanye abantu abane-alopecia areata ephakathi bayachacha kwisithuba sonyaka ngaphandle konyango. Nangona kunjalo, abantu abaninzi bafumana ukuphindaphinda kwiindawo ezingaqhelekanga kwi-scalp.
#Hydrocortisone cream
○ Unyango
Iinaliti ze-Intralesional steroid lolona nyango lusebenzayo. I-Immunotherapy inokuzanywa ukuba iindawo ezinkulu ze-scalp zichaphazelekayo.
#Triamcinolone intralesional injection
#DPCP immunotherapy